EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 25-Jun-2026 10:16 ET (25-Jun-2026 14:16 GMT/UTC)

23-Jun-2026

UT San Antonio study: As FDA approved semaglutide for weight management, calls to poison control centers skyrocketed in the U.S.

University of Texas at San Antonio
Peer-Reviewed Publication

Prior to 2021, poison control centers nationally received roughly 1,000 to 1,500 cases per year. After mid-2021, these volumes nearly doubled, and by 2023 poison centers logged more than 8,000 GLP-1RA-related calls.

Most cases stemmed from unintentional dosing or therapeutic errors rather than deliberate misuse, but the UT San Antonio researchers found the massive increase jarring nonetheless.

Journal: Journal of Medical Toxicology

23-Jun-2026

Can food influence gene activity? Scientists discover a biological “pencil” that improves health through nutrition

Ben-Gurion University of the Negev
Peer-Reviewed Publication

A new international clinical intervention study published in Clinical Nutrition (https://doi.org/10.1016/j.clnu.2026.106701) reveals the molecular and transcriptomic mechanisms through which a dietary intervention may beneficially influence gene expression. The study, led by Prof. Iris Shai and Dr. Hila Zelicha Peer from Ben-Gurion University of the Negev, in collaboration with researchers from Leipzig University, the Leipzig Center of Metabolism (LieCeM), and Harvard University, provides new evidence that specific plant-derived nutrients may function as an “Epigenetic Pencil” – shaping cellular health through nutrition.

Journal: Clinical Nutrition
Funder: Deutsche Forschungsgemeinschaft, Israel Ministry of Health, Israel Ministry of Science and Technology, California Walnuts Commission

23-Jun-2026

CNIC researcher Florian Weinberger awarded ERC Advanced Grant for the project CARDIOSWITCH

Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
Grant and Award Announcement

Florian Weinberger conducts his research within the Regeneration Program at the CNIC.

Funder: European Research Council

23-Jun-2026

ERC Advanced Grant for groundbreaking type 1 diabetes research awarded to Hebrew University researchers Prof. Yuval Dor and Dr. Agnès Klochendler

The Hebrew University of Jerusalem
Grant and Award Announcement

The Hebrew University of Jerusalem proudly congratulates Prof. Yuval Dor and Dr. Agnès Klochendler of the Faculty of Medicine, The Institute for Medical Research Israel-Canada on being awarded the highly competitive European Research Council (ERC) Advanced Grant.

23-Jun-2026

First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington’s disease clinical trial REGEN4HD

UCI Health
Reports and Proceedings

• Huntington’s disease is a genetic disorder that gradually destroys brain cells over the course of 10 to 30 years, typically starting between the ages of 35 and 50

• Phase 1b/2a will evaluate the safety of the treatment and provides hope for those with few options to slow the progression of the disease

• Clinical trial will enroll 21 people with early-stage Huntington’s disease, with 12 participants in a phase 1b dose-escalation group and nine in a phase 2a expansion group

Funder: California Institute for Regenerative Medicine

23-Jun-2026

ERC Advanced Grants for three ground-breaking UCD research projects

UCD Research & Innovation
Grant and Award Announcement

Prestigious awards for pioneering research across anticolonial literary culture, RNAs in medicine, and sustainable energy technologies.

Funder: European Research Council

23-Jun-2026

UC San Diego researcher wins $5.6M NIH Avant Garde Award to prevent HIV, hepatitis C and overdose

University of California - San Diego
Grant and Award Announcement

Innovative project will use AI-powered “digital twins” to help public health agencies better prevent HIV, hepatitis C and overdose among people who use drugs.

23-Jun-2026

New research shows how AI may help avoid unnecessary chemotherapy for breast cancer patients

RCSI
Peer-Reviewed Publication

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune markers that could help doctors more accurately determine which breast cancer patients are unlikely to benefit from chemotherapy, potentially sparing some patients from unnecessary treatment.

Journal: Nature Communications

23-Jun-2026

New framework renders AI trustworthy for cancer subtyping

Vanderbilt University Medical Center
Peer-Reviewed Publication

Reported June 23 in Nature Biomedical Engineering, researchers at Vanderbilt Health and centers in Hong Kong have created a versatile uncertainty-aware AI framework broadly adaptable as a wrapper for digital pathology AI systems. (An AI wrapper acts as an interface layer that customizes, formats and automates how users interact with the underlying intelligence.) They demonstrate their wrapper, called TRUECAM, primarily with reference to non-small cell lung cancer (NSCLC) subtyping using whole-slide images.

Journal: Nature Biomedical Engineering